Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141779 |
| CAS No | NA |
| Mol.F. | C13H10N2O3S |
| Mol.Wt. | 274.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141780 |
| CAS No | NA |
| Mol.F. | C18H21N3O3S |
| Mol.Wt. | 359.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141781 |
| CAS No | NA |
| Mol.F. | C31H30N4O3S2 |
| Mol.Wt. | 570.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141782 |
| CAS No | NA |
| Mol.F. | C37H43N5O3S3 |
| Mol.Wt. | 702.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141783 |
| CAS No | NA |
| Mol.F. | C18H21N3O2S |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141784 |
| CAS No | NA |
| Mol.F. | C13H10N2O2S |
| Mol.Wt. | 258.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141785 |
| CAS No | 2637374-15-1 |
| Mol.F. | C10H8Cl2N2O3 |
| Mol.Wt. | 275.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141786 |
| CAS No | NA |
| Mol.F. | C26H31N5O6 |
| Mol.Wt. | 509.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141787 |
| CAS No | NA |
| Mol.F. | C26H31N5O6 |
| Mol.Wt. | 509.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141788 |
| CAS No | NA |
| Mol.F. | C15H24N4O2 |
| Mol.Wt. | 292.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141789 |
| CAS No | NA |
| Mol.F. | C21H30N4O6 : H2O |
| Mol.Wt. | 434.5 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141790 |
| CAS No | NA |
| Mol.F. | C21H36N4O6 |
| Mol.Wt. | 440.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141791 |
| CAS No | NA |
| Mol.F. | C16H23N3O5 |
| Mol.Wt. | 337.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141792 |
| CAS No | NA |
| Mol.F. | C21H30N4O6 |
| Mol.Wt. | 434.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141793 |
| CAS No | NA |
| Mol.F. | C42H59N7O10 |
| Mol.Wt. | 822.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141794 |
| CAS No | NA |
| Mol.F. | C31H40N4O8 |
| Mol.Wt. | 596.7 |
| INV STATUS | CUSTOM SYNTHESIS |